OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
June 06, 2023
In this episode, Siegfried Schmitt, vice president, Technical at Parexel, discusses the state of biopharma investment in 2023.
June 05, 2023
Reimbursement for Alzheimer's medicines still will occur only with the completion of studies to support full FDA approval.
Adamis Pharmaceuticals announced the closing of its merger with DMK Pharmaceuticals on May 25, 2023.
FDA has published a new system for providing basic and essential information on patient use of drugs and certain biologic products.
June 03, 2023
What factors do CDMOs consider vital to their success?
June 02, 2023
Manufacturers must figure out how flexible they need to be to meet the numerous new requirements of the changing therapeutic and regulatory landscapes.
The future is set to be a running theme for this year’s CPHI event, which will take place in-person at the Fira Barcelona Gran Via in Spain between 24–26 October 2023.
What implications will EMA’s recent regulatory reform have on pharma?
Despite being a relatively small nation, Switzerland is booming for biotech innovation.
Using the four-phased method to assess QRM can ensure continual improvement and that regulatory requirements are met.